Shandong Sinobioway Biomedicine Co., Ltd. (SZSE: 002581)
Health Care · Pharmaceuticals · CN
CN¥5.79
+31.89% today · -20.6% 1Y
Shandong Sinobioway Biomedicine Co., Ltd. (SZSE: 002581) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $568.23M and employs 492 people.
Over the last twelve months the share price has lost 20.6%, trading between 3.04 and 9.25.
Tweenvest scores Shandong Sinobioway Biomedicine Co., Ltd. across four factors: quality 52/100, value 68/100, growth 0/100. Its strongest factor is value.
002581 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $568.23M
- Revenue (TTM)
- $41.08M
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- 0.01
- 52-week high
- CN¥9.25
- 52-week low
- CN¥3.04
- Avg volume (3M)
- —
- Shares outstanding
- 659.74M
- Employees
- 492
- Next earnings
- —
About Shandong Sinobioway Biomedicine Co., Ltd.
Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, manufacture, and sale of chemical raw materials, chemical and pharmaceutical products. Its products include pharmaceutical intermediates and pesticide intermediates. The company was founded on January 18, 2000 and is headquartered in Beijing, China.
- ISIN
- CNE1000012Y5
- Founded
- 1998
- Listed since
- May 20, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.